Tokyo, Japan

Ryosuke Echigo


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryosuke Echigo: Innovator in Vasospasm Treatment

Introduction

Ryosuke Echigo is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of vasospasm. His innovative approach has led to the development of a unique therapeutic agent aimed at addressing critical health issues.

Latest Patents

Echigo holds a patent for a therapeutic or prophylactic agent for vasoconstriction. The primary objective of this invention is to provide an effective agent for treating or preventing vasospasm, including both cerebral and arterial vasospasm. Additionally, it aims to address cerebral ischemia and cerebral infarction. The invention utilizes trehalose as the active ingredient, which helps suppress blood vessel contraction and thickening of the tunica intima and tunica media. This innovative agent offers a promising solution for preventing and treating vasospasm and related diseases.

Career Highlights

Throughout his career, Ryosuke Echigo has worked with esteemed organizations, including Next21 K.K. and the University of Tokyo. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Echigo has collaborated with notable colleagues such as Nobuo Sasaki and Yuichi Tei. Their combined expertise has further advanced the research and development of effective treatments for vasospasm.

Conclusion

Ryosuke Echigo's contributions to medical science, particularly in the treatment of vasospasm, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…